MedTrace Logo

Safety and Efficacy of Persistent Atrial Fibrillation Ablation With a Cryoballoon Technology

NCT06567652 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-08-27

No results posted yet for this study

Summary

The goal of this retrospective observational study is to learn about the safety and efficacy of cryoballoon catheter ablation in 80 patients with persistent atrial fibrillation using the PolarX (Boston scientific) cryoablation technology. The main question it aims to answer is if it is safe and effective.

Conditions

Interventions

DEVICE

catheter ablation

All patients underwent pulmonary vein isolation (and eventually left atrial posterior wall isolation) with the POLARx™ cryoballoon system

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-08-31
Completion
2022-09-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06567652 on ClinicalTrials.gov